Simple blood test could replace risky brain biopsies for tumor tracking
NCT ID NCT06104930
Summary
This study is exploring whether tiny particles in the blood, called extracellular vesicles, can act as a 'liquid biopsy' to monitor meningioma brain tumors. Researchers will track these particles in 60 patients before, during, and after radiation therapy to see if changes in the blood match tumor progression. The goal is to find a safer way to classify and monitor these tumors without needing repeated invasive brain surgeries.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Heidelberg, Radiation Oncology
RECRUITINGHeidelberg, 69120, Germany
Contact
Conditions
Explore the condition pages connected to this study.